Suppr超能文献

卵巢早衰的泌尿生殖道后果的体征和症状、评估及管理

Signs and symptoms, evaluation, and management of genitourinary tract consequences of premature ovarian insufficiency.

作者信息

Calik-Ksepka Anna, Grymowicz Monika, Rudnicka Ewa, Skórska Jolanta, Machura Paulina, Pięta Wojciech, Smolarczyk Roman

机构信息

Department of Gynaecological Endocrinology, Medical University of Warsaw, Warsaw, Poland.

出版信息

Prz Menopauzalny. 2018 Sep;17(3):131-134. doi: 10.5114/pm.2018.78558. Epub 2018 Sep 30.

Abstract

Premature ovarian insufficiency (POI) occurs in 1% of women under 40 years old. Hypoestrogenism associated with this condition may result in vaginal atrophy and urine incontinence, called genitourinary syndrome. The symptoms include: vaginal dryness, irritation, dyspareunia, and dysuria. There is relative lack of studies on the occurrence and treatment of genitourinary problems in women with POI. Prevalence rates vary from 17 to 54% depending on cause, duration of oestrogen depletion, and the treatment used. Patients with POI gain lower scores in tests measuring vaginal health or sexual function in comparison to healthy peers. Hormonal treatment in premature ovarian insufficiency is recommended until the natural age of menopause. The vaginal route of oestrogen administration is supposed to be the criterion standard in treating genitourinary symptoms. Androgen supplementation is not routinely recommended.

摘要

卵巢早衰(POI)发生在1%的40岁以下女性中。与这种情况相关的雌激素缺乏可能导致阴道萎缩和尿失禁,称为生殖泌尿综合征。症状包括:阴道干燥、刺激、性交困难和排尿困难。关于POI女性生殖泌尿问题的发生和治疗的研究相对较少。患病率因病因、雌激素缺乏持续时间和所用治疗方法而异,从17%到54%不等。与健康同龄人相比,POI患者在测量阴道健康或性功能的测试中得分较低。建议对卵巢早衰患者进行激素治疗,直至自然绝经年龄。雌激素经阴道给药途径被认为是治疗生殖泌尿症状的标准方法。一般不建议常规补充雄激素。

相似文献

1
Signs and symptoms, evaluation, and management of genitourinary tract consequences of premature ovarian insufficiency.
Prz Menopauzalny. 2018 Sep;17(3):131-134. doi: 10.5114/pm.2018.78558. Epub 2018 Sep 30.
2
Premature ovarian insufficiency: the context of long-term effects.
J Endocrinol Invest. 2016 Sep;39(9):983-90. doi: 10.1007/s40618-016-0467-z. Epub 2016 Apr 18.
3
Consequences of premature ovarian insufficiency on women's sexual health.
Prz Menopauzalny. 2018 Sep;17(3):127-130. doi: 10.5114/pm.2018.78557. Epub 2018 Sep 30.
4
Premature ovarian insufficiency - hormone replacement therapy and management of long-term consequences.
Prz Menopauzalny. 2018 Sep;17(3):135-138. doi: 10.5114/pm.2018.78559. Epub 2018 Sep 30.
5
Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.
Am J Obstet Gynecol. 2020 Feb;222(2):103-113. doi: 10.1016/j.ajog.2019.08.043. Epub 2019 Aug 29.
7
Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause.
Expert Rev Endocrinol Metab. 2019 Sep;14(5):301-314. doi: 10.1080/17446651.2019.1657008. Epub 2019 Sep 17.
9
The Genitourinary Syndrome of Menopause: An Overview of the Recent Data.
Cureus. 2020 Apr 8;12(4):e7586. doi: 10.7759/cureus.7586.
10
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.
Front Endocrinol (Lausanne). 2019 Aug 21;10:561. doi: 10.3389/fendo.2019.00561. eCollection 2019.

引用本文的文献

1
Primary ovarian insufficiency: update on clinical and genetic findings.
Front Endocrinol (Lausanne). 2024 Sep 26;15:1464803. doi: 10.3389/fendo.2024.1464803. eCollection 2024.
2
Health-related quality-of-life among patients with premature ovarian insufficiency: a systematic review and meta-analysis.
Qual Life Res. 2020 Jan;29(1):19-36. doi: 10.1007/s11136-019-02326-2. Epub 2019 Oct 16.

本文引用的文献

1
Influence of Sexual Function on the Social Relations and Quality of Life of Women with Premature Ovarian Insufficiency.
Rev Bras Ginecol Obstet. 2018 Feb;40(2):66-71. doi: 10.1055/s-0037-1615289. Epub 2018 Feb 28.
2
Genitourinary Syndrome of Menopause: Management Strategies for the Clinician.
Mayo Clin Proc. 2017 Dec;92(12):1842-1849. doi: 10.1016/j.mayocp.2017.08.019.
3
Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis.
Maturitas. 2017 Sep;103:78-88. doi: 10.1016/j.maturitas.2017.06.029. Epub 2017 Jun 27.
4
Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.
Fertil Steril. 2016 Dec;106(7):1588-1599. doi: 10.1016/j.fertnstert.2016.09.046.
5
Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management.
Am J Obstet Gynecol. 2016 Dec;215(6):704-711. doi: 10.1016/j.ajog.2016.07.045. Epub 2016 Jul 26.
6
ESHRE Guideline: management of women with premature ovarian insufficiency.
Hum Reprod. 2016 May;31(5):926-37. doi: 10.1093/humrep/dew027. Epub 2016 Mar 22.
7
Treatment of the genitourinary syndrome of menopause.
Climacteric. 2015;18 Suppl 1:23-9. doi: 10.3109/13697137.2015.1079100.
8
Vaginal epithelium and microflora characteristics in women with premature ovarian failure under hormone therapy compared to healthy women.
Arch Gynecol Obstet. 2015 Jul;292(1):159-64. doi: 10.1007/s00404-015-3616-2. Epub 2015 Jan 22.
9
Role of the different sexuality domains on the sexual function of women with premature ovarian failure.
J Sex Med. 2015 Mar;12(3):685-9. doi: 10.1111/jsm.12743. Epub 2014 Nov 6.
10
Dyspareunia and lubrication in premature ovarian failure using hormonal therapy and vaginal health.
Climacteric. 2014 Aug;17(4):342-7. doi: 10.3109/13697137.2013.860116. Epub 2013 Dec 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验